Cargando…
A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece
SIMPLE SUMMARY: Soft tissue sarcomas (STS) constitute a group of heterogeneous tumors. For patients with advanced or metastatic disease, prognosis is poor and only a few treatments are available, including trabectedin. The aim of our prospective multicenter study was to evaluate the real-world activ...
Autores principales: | Kokkali, Stefania, Boukovinas, Ioannis, Samantas, Epaminondas, Papakotoulas, Pavlos, Athanasiadis, Ilias, Andreadis, Charalampos, Makrantonakis, Parisis, Samelis, Georgios, Timotheadou, Eleni, Vassilopoulos, Georgios, Papadimitriou, Christos, Tzanninis, Dimitrios, Ardavanis, Alexandros, Kotsantis, Ioannis, Karvounis-Marolachakis, Kiki, Theodoropoulou, Theodora, Psyrri, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031293/ https://www.ncbi.nlm.nih.gov/pubmed/35454787 http://dx.doi.org/10.3390/cancers14081879 |
Ejemplares similares
-
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022) -
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
por: Tsoukalas, Nikolaos, et al.
Publicado: (2020) -
Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study
por: Kotsakis, Athanasios, et al.
Publicado: (2019) -
Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers
por: Kokkali, Stefania, et al.
Publicado: (2023) -
Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group
por: Kokkali, Stefania, et al.
Publicado: (2022)